Chromatin control of human cytomegalovirus infection
mBio · 2023
DOI: 10.1128/mbio.00326-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift mBio, 2023. Verfasst von Stephen M Matthews und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infection Biology, Global Center for Pathogen and Human Health Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Chromatin, Cytomegalovirus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Human cytomegalovirus (HCMV) is a betaherpesvirus that establishes lifelong infection in its host and can cause severe comorbidities in individuals with suppressed or compromised immune systems. The lifecycle of HCMV consists of lytic and latent phases, largely dependent upon the cell type infected and whether transcription from the major immediate early locus can ensue. Control of this locus, which acts as a critical “switch” region from where the lytic gene expression cascade originates, as well as regulation of the additional ~235 kilobases of virus genome, occurs through chromatinization with cellular histone proteins after infection. Upon infection of a host cell, an initial intrinsic antiviral response represses gene expression from the incoming genome, which is relieved in permissive cells by viral and host factors in concert. Latency is established in a subset of hematopoietic cells, during which viral transcription is largely repressed while the genome is maintained. As these latently infected cells differentiate, the cellular milieu and epigenetic modifications change, giving rise to the initial stages of virus reactivation from latency. Thus, throughout the cycle of infection, chromatinization, chromatin modifiers, and the recruitment of specific transcription factors influence the expression of genes from the HCMV genome. In this review, we discuss epigenetic regulation of the HCMV genome during the different phases of infection, with an emphasis on recent reports that add to our current perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection Biology, Global Center for Pathogen and Human Health Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio, USA.
- Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic , Cleveland, Ohio, USA.
ORCID-Profile: Stephen M Matthews, Ian J Groves, Christine M O'Connor
Förderung
- NIAID NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Matthews, S. M., Groves, I. J., & O'Connor, C. M. (2023). Chromatin control of human cytomegalovirus infection. mBio. https://doi.org/10.1128/mbio.00326-23
Vancouver
Matthews SM, Groves IJ, O'Connor CM. Chromatin control of human cytomegalovirus infection. mBio. 2023. doi:10.1128/mbio.00326-23
BibTeX
@article{Matthews2023,
author = {Matthews, Stephen M and Groves, Ian J and O'Connor, Christine M},
title = {Chromatin control of human cytomegalovirus infection},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.00326-23}
}
EUVIMED